MMP-9-mediated VEGF release contributes to tumor vascularization.209,210 Targeting these angiogenic pathways offers potential therapeutic avenues, with combination therapies addressing VEGF resistance through simultaneous inhibition of complementary pathways. This evidence concerns the gene VEGFA and neoplasm.